Skip to main content
Erschienen in: Obesity Surgery 3/2019

27.11.2018 | Original Contributions

Safety and Efficacy of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Used for Analgesia After Bariatric Surgery: A Retrospective Case-Control Study

verfasst von: Hicham Abou Zeid, Rita Kallab, Marie Antoinette Najm, Hisham Jabbour, Roger Noun, Fadi Sleilati, Salim Chucri, Christine Dagher, Ghassan Sleilaty, Nicole Naccache

Erschienen in: Obesity Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Non-steroidal anti-inflammatory drugs (NSAIDs) are cornerstone in multimodal analgesia protocols. This point is of great value in morbidly obese patients due to the high prevalence of restrictive pulmonary disease and obstructive sleep apnea. The aim of this study was to test the hypothesis that NSAIDs do not increase acute bariatric surgery complications while optimizing postoperative analgesia.

Methods

Databases of two medical centers were retrospectively reviewed to find all patients who underwent bariatric surgery between 1 January 2017 and 31 December 2017. Inclusion criteria were BMI greater than 30 kg/m2 and age of 16–75 years old. Patients who suffered from severe organ failure or coagulation disorders were excluded. Patient’s demographics, obesity-related diseases (diabetes, hypertension, dyslipidemia), postoperative pain scores, and morphine consumption in PACU, as well as early and late surgical complications, were collected. Patients included from the first institution (where NSAIDs analgesia was prohibited: control group) were compared to patients from the second institution (where NSAIDs analgesia was mandatory: case group).

Results

The study population included 270 patients, 134 in the control group, and 136 in the case group. NSAIDs usage produced better analgesia with significant reduction in morphine consumption and PACU length of stay. Also, incidence of surgical complications was the same in the two groups.

Conclusions

NSAIDs administration do not increase postoperative complication rate after bariatric surgery. Although NSAID administration provided better analgesia and shorter PACU stay, future prospective studies are needed to confirm these encouraging results and to evaluate their impact on postoperative rehabilitation.
Literatur
1.
Zurück zum Zitat Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin N Am. 2016;45(4):571–9.CrossRef Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin N Am. 2016;45(4):571–9.CrossRef
2.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama. 2004;292(14):1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama. 2004;292(14):1724–37.CrossRefPubMed
4.
Zurück zum Zitat Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1(6):530–5. discussion 535-6CrossRefPubMed Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1(6):530–5. discussion 535-6CrossRefPubMed
5.
Zurück zum Zitat McDaid C et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review. Health Technol Assess. 2010;14(17):1–153. iii-ivCrossRefPubMed McDaid C et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review. Health Technol Assess. 2010;14(17):1–153. iii-ivCrossRefPubMed
6.
Zurück zum Zitat Whistance RN, Forsythe RO, McNair AGK, et al. A systematic review of outcome reporting in colorectal cancer surgery. Color Dis. 2013;15(10):e548–60.CrossRef Whistance RN, Forsythe RO, McNair AGK, et al. A systematic review of outcome reporting in colorectal cancer surgery. Color Dis. 2013;15(10):e548–60.CrossRef
7.
Zurück zum Zitat Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302–8.CrossRefPubMedPubMedCentral Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Coblijn UK, Lagarde SM, de Castro SMM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRefPubMed Coblijn UK, Lagarde SM, de Castro SMM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRefPubMed
9.
Zurück zum Zitat Sverden E et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRefPubMed Sverden E et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRefPubMed
10.
Zurück zum Zitat Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96(13):7563–8.CrossRefPubMedPubMedCentral Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96(13):7563–8.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Collaborative ST. Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after gastrointestinal surgery. Br J Surg. 2014;101(11):1413–23.CrossRef Collaborative ST. Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after gastrointestinal surgery. Br J Surg. 2014;101(11):1413–23.CrossRef
12.
Zurück zum Zitat Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal antiinflammatory drugs on patientcontrolled analgesia morphine side effects: metaanalysis of randomized controlled trials. Anesthesiology. 2005;102:1249–60.CrossRefPubMed Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal antiinflammatory drugs on patientcontrolled analgesia morphine side effects: metaanalysis of randomized controlled trials. Anesthesiology. 2005;102:1249–60.CrossRefPubMed
13.
Zurück zum Zitat Xinyu Zhang PTD, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology. 2017;18:256.CrossRefPubMedPubMedCentral Xinyu Zhang PTD, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology. 2017;18:256.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Curiel RV, Katz JD. Mitigating the cardiovascular and renal effects of NSAIDs. Pain Med. 2013;14(Suppl 1):S23–8.CrossRef Curiel RV, Katz JD. Mitigating the cardiovascular and renal effects of NSAIDs. Pain Med. 2013;14(Suppl 1):S23–8.CrossRef
15.
Zurück zum Zitat Okamura A, Watanabe M, Imamura Y, et al. Preoperative glycosylated hemoglobin levels predict anastomotic leak after esophagectomy with cervical esophagogastric anastomosis. World J Surg. 2017;41(1):200–7.CrossRefPubMed Okamura A, Watanabe M, Imamura Y, et al. Preoperative glycosylated hemoglobin levels predict anastomotic leak after esophagectomy with cervical esophagogastric anastomosis. World J Surg. 2017;41(1):200–7.CrossRefPubMed
16.
Zurück zum Zitat Ding N, Mao Y, He J, et al. Experiences in the management of anastomotic leakages and analysis of the factors affecting leakage healing in patients with esophagogastric junction cancer. J Thorac Dis. 2017;9(2):386–91.CrossRefPubMedPubMedCentral Ding N, Mao Y, He J, et al. Experiences in the management of anastomotic leakages and analysis of the factors affecting leakage healing in patients with esophagogastric junction cancer. J Thorac Dis. 2017;9(2):386–91.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Vorwald P et al. Laparoscopic Roux-en-Y gastric bypass after open vertical banded gastroplasty in patient with severe GERD. Obes Surg. 2017:1–1. Vorwald P et al. Laparoscopic Roux-en-Y gastric bypass after open vertical banded gastroplasty in patient with severe GERD. Obes Surg. 2017:1–1.
18.
Zurück zum Zitat Nguyen NT, Ho HS, Palmer LS, et al. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 2000;191(2):149–55. discussion 155-7CrossRefPubMed Nguyen NT, Ho HS, Palmer LS, et al. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 2000;191(2):149–55. discussion 155-7CrossRefPubMed
19.
Zurück zum Zitat White S, Han SH, Lewis C, et al. Selective approach to use of upper gastroesophageal imaging study after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(2):122–5.CrossRefPubMed White S, Han SH, Lewis C, et al. Selective approach to use of upper gastroesophageal imaging study after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(2):122–5.CrossRefPubMed
20.
Zurück zum Zitat Burton TP, M. A, Soop M. Nonsteroidal antiinflammatory drugs and anastomotic dehiscence in bowel surgery: systematic review and meta-analysis of randomized, controlled trials. Dis Colon Rectum. 2013;56:126–34.CrossRefPubMed Burton TP, M. A, Soop M. Nonsteroidal antiinflammatory drugs and anastomotic dehiscence in bowel surgery: systematic review and meta-analysis of randomized, controlled trials. Dis Colon Rectum. 2013;56:126–34.CrossRefPubMed
21.
Zurück zum Zitat Gorissen KJ, B. D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal antiinflammatory drugs in colorectal surgery. Br J Surg. 2012;99:721–7.CrossRefPubMed Gorissen KJ, B. D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal antiinflammatory drugs in colorectal surgery. Br J Surg. 2012;99:721–7.CrossRefPubMed
22.
Zurück zum Zitat Ferraz AA, Cowles VE, Condon RE, et al. Nonopioid analgesics shorten the duration of postoperative ileus. Am Surg. 1995;61(12):1079–83.PubMed Ferraz AA, Cowles VE, Condon RE, et al. Nonopioid analgesics shorten the duration of postoperative ileus. Am Surg. 1995;61(12):1079–83.PubMed
23.
Zurück zum Zitat Lyons, M.M., et al. Symptomless multi-variable apnea prediction index assesses obstructive sleep apnea risk and adverse outcomes in elective surgery. Sleep, 2017 40(3). Lyons, M.M., et al. Symptomless multi-variable apnea prediction index assesses obstructive sleep apnea risk and adverse outcomes in elective surgery. Sleep, 2017 40(3).
Metadaten
Titel
Safety and Efficacy of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Used for Analgesia After Bariatric Surgery: A Retrospective Case-Control Study
verfasst von
Hicham Abou Zeid
Rita Kallab
Marie Antoinette Najm
Hisham Jabbour
Roger Noun
Fadi Sleilati
Salim Chucri
Christine Dagher
Ghassan Sleilaty
Nicole Naccache
Publikationsdatum
27.11.2018
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3608-y

Weitere Artikel der Ausgabe 3/2019

Obesity Surgery 3/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.